Impact of the non-cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities

被引:52
作者
Cretu, Alexandra
Brooks, Peter C.
机构
[1] NYU, Sch Med, Inst Canc, Dept Radiat Oncol, New York, NY 10016 USA
[2] NYU, Sch Med, Inst Canc, Dept Cell Biol, New York, NY 10016 USA
关键词
D O I
10.1002/jcp.21222
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Evidence is accumulating that the malignant phenotype of a given tumor is dependent not only on the intrinsic characteristics of tumor cells, but also on the cooperative interactions of non-neoplastic cells, soluble secreted factors and the non-cellular solid-state ECM network that comprise the tumor microenvironment. Given the ability of the tumor microenvironment to regulate the cellular phenotype, recent efforts have focused on understanding the molecular mechanisms by which cells sense, assimilate, interpret, and ultimately respond to their immediate surroundings. Exciting new studies are beginning to unravel the complex interactions between the numerous cell types and regulatory factors within the tumor microenvironment that function cooperatively to control tumor cell invasion and metastasis. Here, we will focus on studies concerning a common theme, which is the central importance of the non-cellular solid-state compartment as a master regulator of the malignant phenotype. We will highlight the non-cellular solid-state compartment as a relatively untapped source of therapeutic and imaging targets and how cellular interactions with these targets may regulate tumor metastasis.
引用
收藏
页码:391 / 402
页数:12
相关论文
共 128 条
[1]   Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin [J].
Akaht, Abebe ;
Roth, Jennifer M. ;
Caunt, Maresa ;
Policarpio, Desiree ;
Liebes, Leonard ;
Brooks, Peter C. .
CANCER RESEARCH, 2007, 67 (09) :4353-4363
[2]   The COOH-terminal globular domain of fibrinogen γ chain suppresses angiogenesis and tumor growth [J].
Akakura, Nobuaki ;
Hoogland, Case ;
Takada, Yoko K. ;
Saegusa, Jun ;
Ye, Xiaojing ;
Liu, Fu-Tong ;
Cheung, Anthony Tze-Wai ;
Takada, Yoshikazu .
CANCER RESEARCH, 2006, 66 (19) :9691-9697
[3]   Targeting integrins for the control of tumour angiogenesis [J].
Akalu, A ;
Cretu, A ;
Brooks, PC .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (12) :1475-1486
[4]  
AKALU A, 2007, ANTI ANGIOGENEIC CAN, P273
[5]  
AKALU A, 2005, ENCY MOL CELL BIOL M, P47
[6]  
ALMHENDI AB, 2000, NAT MED, V6, P100
[7]   The multifaceted roles of chemokines in malignancy [J].
Ben-Baruch, A. .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :357-371
[8]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[9]   Activated vitronectin as a target for anticancer therapy with human antibodies [J].
Bloemendal, HJ ;
de Boer, HC ;
Koop, EA ;
van Dongen, AJ ;
Goldschmeding, R ;
Landman, WJM ;
Logtenberg, T ;
Gebbink, MFBG ;
Voest, EE .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (09) :799-808
[10]   L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer [J].
Boo, Yoon-Jung ;
Park, Joong-Min ;
Kim, Jin ;
Chae, Yang-Seok ;
Min, Byung-Wook ;
Um, Jun-Won ;
Moon, Hong-Young .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (05) :1703-1711